BlackRock Technology and Private Equity Term Trust
BTX · NYSE
$8.60+$0.00 (+0.00%)TodayMarket closed ·
Prev close $8.60
About BTX
- Employees
- 0
- Headquarters
- Wilmington, Delaware
- Listed
- Mar 26, 2021
- Sector
- N/A
- Industry
- N/A
- Website
- blackrock.com
Leadership
| Name | Title | Since |
|---|---|---|
| R. Glenn Hubbard | — | — |
| John Perlowski | — | 2020 |
| W. Carl Kester | — | — |
| Trent Walker | — | — |
| Charles Park | — | — |
| Jonathan Diorio | — | — |
| Jay Fife | — | — |
| Janey Ahn | — | — |
| Cynthia Egan | — | — |
| Frank Fabozzi | — | — |
| Lorenzo Flores | — | — |
| Stayce Harris | — | — |
| J. Phillip Holloman | — | — |
| Catherine Lynch | — | — |
| Robert Fairbairn | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2020: $5.80M total revenue
By product
- Subscription Revenue [Member]$4.88M84.2%
- Other Revenue [Member]$492.00K8.5%
- Hardware Revenue [Member]$426.00K7.3%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Citius Pharmaceuticals CTXR | Supplier and customer | 0.81 |
| Factor Bioscience, Inc. | Supplier and customer | — |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.